References
- Accuracy of the references is the responsibility of the author.
- Straus SE. History of chronic fatigue syndrome. Rev Infect Dis 1991: 13(Suppl 1): S2–7
- Acheson ED. The clinical syndrome variously called benign myalgic encephalomyelitis, Iceland disease, and epidemic neuromyasthenia. Am J Med 1959: 26(Apr): 569–95
- Holmes GP, Kaplan JE, Stewart JA, et al. A cluster of patients with a chronic mononucleosis—like syndrome: is Epstein-Barr virus the cause? JAMA 1987: 257(17): 2297–302
- Bell DS, Bell KM. The post-infectious chronic fatigue syndrome: diagnosis in childhood. In: Ablashi DV, Faggioni A, Krueger GR, et al, eds. Epstein-Barr virus and human disease 1988. Clifton, NJ: Humana Press, 1989: 412–7
- Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988: 108(3): 387–9
- Komaroff AL, Straus SE, Gantz NM, et al. The chronic fatigue syndrome. (Letter) Ann Intern Med 1989: 110(5): 407–8
- Komaroff AL, Buchwald D. Symptoms and signs of chronic fatigue syndrome. Rev Infect Dis 1991: 13(Suppl 1): S8–11
- Lane TJ, Manu P, Matthews DA. Depression and somatization in the chronic fatigue syndrome. Am J Med 1991: 91(10): 335–44
- Goldenberg DL, Simms RW, Geiger A, et al. High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis Rheum 1990: 33(3): 381–7
- Bell DS, Bell KM. Chronic fatigue syndrome: diagnostic criteria. (Letter) Ann Intern Med 1988: 109(2): 167
- Buchwald D, Komaroff AL. Review of laboratory findings for patients with chronic fatigue syndrome. Rev Infect Dis 1991: 13(Suppl 1): S12–8
- Klimas NG, Salvato FR, Morgan R, et al. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990: 28(6): 1403–10
- Caligiuri M, Murray C, Buchwald D, et al. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol 1987: 139(10): 3306–13
- Landay AL, Jessop C, Lennette ET, et al. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet 1991: 338(8769): 707–12
- Lloyd AR, Hickie I, Brockman A, et al. Cytokine levels in serum and cerebrospinal fluid in patients with chronic fatigue syndrome and control subjects. J Infect Dis 1991: 164(Nov): 1023–4
- Gantz NM, Holmes GP. Treatment of patients with chronic fatigue syndrome. Drugs 1989: 38(6): 855–62
- DuBois RE. Gamma globulin therapy for chronic mononucleosis syndrome. AIDS Res 1986: 2(Suppl 1): S191–5
- Cox IM, Campbell MJ, Dowson D. Red blood cell magnesium and chronic fatigue syndrome. Lancet 1991: 337(Mar 30): 757–60
- Lloyd A, Hickie I, Wakefield D, et al. A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. Am J Med 1990: 89(Nov): 561–8
- Peterson PK, Shepard J, Macres M, et al. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. Am J Med 1990: 89(Nov): 554–60
- DeFreitas E, Hilliard B, Cheney PR, et al. Retroviral sequences related to human T-Iymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome. Proc Natl Acad Sci USA 1991: 88(Apr): 2922–6
- Cotton P. Treatment proposed for chronic fatigue syndrome; research continues to compile data on disorder. JAMA 1991: 266(19): 2667